Advertisement

Actelion to appeal damages order

AFP
AFP - [email protected]
Actelion to appeal damages order

Swiss biotechnology group Actelion said Wednesday that it would appeal against $547 million in damages awarded by a California court to Japanese company Asahi Kasei Pharma.

Advertisement

Actelion said in a statement that it had also filed a short-term court motion to try to pare down compensation, partly due to previous arbitration on the issue.

"The company will file appropriate further post-trial motions and will appeal the entire judgment," it added.

It believes the ruling is "neither supported by the facts nor is it correct as a matter of law."

The dispute dates back to November 2008 when Asahi filed suit over the cancellation of an agreement with Actelion subsidiary Cotherix to licence and develop a drug compound called fasudil.

Its current motion is asking for a choice to be made between damages of $358.95 million for alleged lost profits or $187.4 million in alleged development costs; and for an additional deduction of $78.4 million due to previous arbitration.

The biotech firm noted that punitive damages of 30 million dollars had also been awarded against some company executives.

More

Comments

Join the conversation in our comments section below. Share your own views and experience and if you have a question or suggestion for our journalists then email us at [email protected].
Please keep comments civil, constructive and on topic – and make sure to read our terms of use before getting involved.

Please log in to leave a comment.

See Also